|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||14.97 - 15.07|
|52 Week Range||11.65 - 17.73|
|Beta (5Y Monthly)||1.34|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||0.59 (3.98%)|
|Ex-Dividend Date||Apr 28, 2021|
|1y Target Est||17.20|
Bayer Aktiengesellschaft (BAYRY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Merck (MRK)/Bayer's (BAYRY) vericiguat gets approval for symptomatic chronic heart failure in patients with reduced ejection fraction in Europe.
Monheim – Bayer announced the European launch of its global Carbon Initiative. The main goal is the decarbonization of the food value chain focusing on farmers’ activities for a more resilient and ...